My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solid Biosciences Inc. - Common Stock (NQ:SLDB)

5.410 -0.080 (-1.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 715,021
Open 5.510
Bid (Size) 5.420 (1)
Ask (Size) 5.610 (1)
Prev. Close 5.490
Today's Range 5.400 - 5.610
52wk Range 2.410 - 8.100
Shares Outstanding 19,601,539
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Federal Reserve Poised for September Rate Cut Amidst High Market Expectations and Powell's Jackson Hole Address
Investor sentiment is overwhelmingly pointing towards a significant shift in the Federal Reserve's monetary policy, with a near-certainty of a 25-basis-point interest rate cut anticipated at its... 
Via MarketMinute
Topics Bonds Credit Cards Economy
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside
Per two Wall Street analysts, one of 2025's biggest losers could be set up for a stunning recovery. They see over 175% upside in Sarepta Therapeutics. 
Via MarketBeat
Topics Death

Performance

YTD
+38.7%
+38.7%
1 Month
-10.3%
-10.3%
3 Month
+17.4%
+17.4%
6 Month
+9.7%
+9.7%
1 Year
-28.2%
-28.2%

More News

Read More
Solid Biosciences Stock Pops On US, Canada Nod For Gene Therapy Trials: Retail Buzz Spikes
Via Stocktwits
Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand
Via Benzinga
Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
Via MarketBeat
Topics Earnings
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Via Benzinga
Can Solid Biosciences Challenge Sarepta in the DMD Market?
Via MarketBeat
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
From Climb Bio, Inc.
Via GlobeNewswire
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week
Via Stocktwits
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
Via MarketBeat
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?
Via Stocktwits
Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data
Via Benzinga
Stocks Quiet As S&P 500 Nears All-Time High
Via Talk Markets
Topics Stocks Stocks / Equities
Tuesday's session: gap up and gap down stocks
Via Chartmill
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
Via Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
SLDB Stock Earnings: Solid Biosciences Beats EPS for Q2 2024
Via InvestorPlace

Frequently Asked Questions

Is Solid Biosciences Inc. - Common Stock publicly traded?
Yes, Solid Biosciences Inc. - Common Stock is publicly traded.
What exchange does Solid Biosciences Inc. - Common Stock trade on?
Solid Biosciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Solid Biosciences Inc. - Common Stock?
The ticker symbol for Solid Biosciences Inc. - Common Stock is SLDB on the Nasdaq Stock Market
What is the current price of Solid Biosciences Inc. - Common Stock?
The current price of Solid Biosciences Inc. - Common Stock is 5.410
When was Solid Biosciences Inc. - Common Stock last traded?
The last trade of Solid Biosciences Inc. - Common Stock was at 09/16/25 04:00 PM ET
What is the market capitalization of Solid Biosciences Inc. - Common Stock?
The market capitalization of Solid Biosciences Inc. - Common Stock is 106.04M
How many shares of Solid Biosciences Inc. - Common Stock are outstanding?
Solid Biosciences Inc. - Common Stock has 106M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.